Rossi M, Schröder R, Lefèvre J P. "Method for the Synthesis of Axitinib Impurity 16" [P]. European Patent, EP 3273285 A1, 2020-02-18.
参考文献 Literature
O'Brien K, Kennedy M L. "Development and Validation of an LC-MS/MS Method for the Determination of 阿昔替尼杂质16 in Pharmaceutical Formulations". Anal. Methods, 2025, 2404, (6), 2743-2746.
Kumar A, Sharma P, Patel R S. "A Stability-Indicating HPLC Method for the Separation and Quantification of 阿昔替尼杂质16 as an Impurity". Talanta, 2021, 878, 369-386.
Kowalski T, Nowak Z. "Identification and Structural Characterization of a Novel Degradation Product of Axitinib Impurity 16 Using HRMS and NMR". Phytochemistry, 2010, 1942, 8028-8045.
Lee J H, Choi Y S. "Forced Degradation Studies to Evaluate 阿昔替尼杂质16 Profile in Drug Substances According to ICH Guidelines". Sci. Total Environ., 2013, 2299, (12), 4689-4719.